Contact:
sales@biotechnologyforums.com to feature here

  •  Previous
  • 1
  • ...
  • 4
  • 5
  • 6
  • 7(current)
  • 8
  • Next 
Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
DBT BET ~ JRF/NET 2017 RESEARCH FELLOW
#25
39. Statins are very effective against hypercholesterolemia, a major cause of
atherosclerosis. These drugs reduce plasma cholesterol levels by
(A) Preventing absorption of cholesterol from the intestine.
(B) Increasing the excretion of cholesterol from the body via conversion
to bile acids.
© Inhibiting the conversion of 3-hydroxy-3-methylglutaryl-CoA to
mevalonate in the pathway for cholesterol biosynthesis.
(D) Increasing the rate of degradation of 3-hydroxy-3-methylglutaryl CoA
reductase.
40. Measles, Mumps, Rubella-MMR combined vaccine represents which one of
following vaccine categories?
(A)Inactivated/killed
(B) Live, attenuated
©Subunit
(D)Toxoid (inactivated toxin)
41. A haemophiliac man marries a normal woman. They have a daughter who
does not show symptoms of haemophilia. If she marries a haemophiliac man,
what will be the probability of their son displaying symptoms of haemophilia?
(A)0%
(B) 25%
© 50%
(D)100%
42. The conventional treatment for methanol toxicity is to administer ethanol.
Which of the following explains the basis of this treatment?
(A) Ethanol acts as a competitive inhibitor to methanol
(B) Ethanol acts as a non-competitive inhibitor to methanol
© Ethanol destroys the enzymatic activity of alcohol dehydrogenase
(D) Ethanol blocks the entry of methanol within the cells.
43. What will be the angular velocity of a rotor in a centrifuge operating at 6000
revolution per minute?
(A) 62.8 radians per second
(B) 628 radians per second
© 6.28 radians per second
(D) 6280 radians per second
#26
Immunological decision-making: how does the immune system decide to mount a helper T-cell response?

Aberrant T-cell responses underpin a range of diseases, including asthma and allergy and autoimmune diseases. Pivotal immune elements of these diseases are the development of antigen-specific effector T-helper type 2 (Th2) cells, Th1 cells, or the recently defined Th17 cells that are associated with the clinical features and disease progression. In order to identify crucial processes in the pathogenesis of these diseases it is critical to understand how the development of these T cells occurs. The phenotype of a polarized T-cell that differentiates from a naïve precursor is determined by the complex interaction of antigen-presenting cells with naïve T cells and involves a multitude of factors, including the dominant cytokine environment, costimulatory molecules, type and load of antigen presented and a plethora of signaling cascades. The decision to take the immune response in a certain direction is not made by one signal alone, instead many different elements act synergistically, antagonistically and through positive feedback loops to activate a Th1, Th2, or Th17 immune response. The elucidation of the mechanisms of selection of T-cell phenotype will facilitate the development of therapeutic strategies to intervene in the development of deleterious T-cell responses. This review will focus on the pathways and key factors responsible for the differentiation of the various subsets of effector CD4 T cells. We will primarily discuss what is known of the Th1 and Th2 differentiation pathways, while also reviewing the emerging research on Th17 differentiation.

Keywords: dendritic cell, polarization, T-cell, Th1, Th2, Th17
INTRODUCTION: T-HELPER CELL SUBSETS
Naive T helper (Th) cells are activated by recognition of a peptide antigen–class II major histocompatibility complex (MHC) presented on antigen-presenting cells (APCs) through the interaction with the T-cell receptor (TCR). After activation, Th cells begin to divide and/or give rise to a clone of effector cells, each specific for the same antigen–class II MHC complex.1 These effector Th cells are CD4+ and can be divided into three main types, with distinct cytokine-secretion phenotypes eliciting unique functional characteristics for each type. These cells are referred to as Th type-1 (Th1), Th type-2 (Th2) or Th type-17 (Th17) cells, depending on their phenotype. Th1 cells secrete the cytokines interferon (IFN)-γ, and tumour necrosis factor (TNF)-β, which allow these cells to be particularly effective in protecting against intracellular infections by viruses and bacteria and micro-organisms that grow in macrophages, as well as eliminating cancerous cells.2,3 Th2 cells secrete interleukin (IL-4), -5, -10 and -13, which up-regulate antibody production and target parasitic organisms. Th2 cells activate B cells, which are adapted for defence against parasites that are vulnerable to IL-4-switched immunoglobulin (Ig)E production, IL-5-induced eosinophilia, and IL-3- and IL-4-stimulated mast cell proliferation and degranulation. Th2 cells are predominately responsible for the development of asthma. Until recently the latter two subsets were considered to be the only types of CD4 effector responses; however, studies over the last few years have revolutionized this area of immunology with the discovery of a third subset known as Th17 cells.
#27
DBT BET JRF - 2017
HALL TICKET. DOWNLOAD



https://cdn.digialm.com/EForms/configure...login.html

https://www.digialm.com/EForms/html/form...index.html




My GATE AND BET JRF CENTER IS SAME ..... O GOD U GREAT......
#28
so we can start discussion on todays paper dbt jrf
  

Possibly Related Threads...
Thread
Author
  /  
Last Post
Replies: 92
Views: 17,594
06-19-2017, 05:23 PM
Last Postswarnava
Replies: 18
Views: 11,027
02-14-2017, 01:40 AM
Last Postsj26
Replies: 2
Views: 2,135
12-23-2016, 03:38 PM
Last PostDEEP CHANDA
Replies: 1
Views: 11,799
10-04-2016, 04:42 PM
Last PostSunilNagpal



Users browsing this thread:
2 Guest(s)

DBT BET ~ JRF/NET 2017 RESEARCH FELLOW00